Narrow search
Showing 1 - 10 of 203
Cover Image
Impact of Transformation of Negative Values and Regression Models on Differences Between the UK and US EQ-5D Time Trade-Off Value Sets
Augestad, Liv Ariane; Rand-Hendriksen, Kim; … - In: PharmacoEconomics 30 (2012) 12, pp. 1203-1214
Background:Background: National EQ-5D value sets are developed because preferences for health may vary in different populations. UK values are lower than US values for most of the 243 possible EQ-5D health states. Although similar protocols were used for data collection, analytic choices...
Persistent link: https://www.econbiz.de/10011005072
Cover Image
EQ-5D versus SF-6D in an Older, Chronically Ill Patient Group
Gerard, Karen; Nicholson, Tricia; Mullee, Mark; Mehta, Raj - In: Applied Health Economics and Health Policy 3 (2004) 2, pp. 91-102
Choosing between preference-based instruments of health-related quality of life (HR-QOL) in particular situations is an important area for research. Even where instruments can be assumed to be measuring the same thing, they may not be interchangeable. The study presented investigates the extent...
Persistent link: https://www.econbiz.de/10005243068
Cover Image
NICE Says No to Inhaled Insulin: What Lessons Should We Learn?
Freemantle, Nick - In: PharmacoEconomics 24 (2006) 7, pp. 627-629
Persistent link: https://www.econbiz.de/10005243098
Cover Image
The NICE Reference Case Requirement: More Pain for What, if Any, Gain?
Gafni, Amiram; Birch, Stephen - In: PharmacoEconomics 22 (2004) 4, pp. 271-273
Persistent link: https://www.econbiz.de/10005243128
Cover Image
A Review of Health-Utility Data for Osteoarthritis: Implications for Clinical Trial-Based Evaluation
Ruchlin, Hirsch S.; Insinga, Ralph P. - In: PharmacoEconomics 26 (2008) 11, pp. 925-935
The objective of this review was to describe the performance of health-utility measures in valuing the quality-of-life (QOL) impact of changes in osteoarthritis (OA)-related chronic pain when administered within a clinical trial setting. Because the collection of utility data within a clinical...
Persistent link: https://www.econbiz.de/10005243134
Cover Image
A Review of Quality-of-Life Evaluations in Patients with Congestive Heart Failure
Berry, Colin; McMurray, John - In: PharmacoEconomics 16 (1999) 3, pp. 247-271
The factors that may lead to an impaired quality of life in congestive heart failure (CHF) are physical symptoms, psychological problems, treatment adverse effects and social limitation. There are now several general and disease-specific quality-of-life (QOL) questionnaires which have been used...
Persistent link: https://www.econbiz.de/10005243138
Cover Image
A Review of Quality of Life in Alzheimer's Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects
McKenna, Stephen P.; Doward, Lynda C. - In: PharmacoEconomics 16 (1999) 4, pp. 417-419
Persistent link: https://www.econbiz.de/10005243154
Cover Image
Psychometric Validation of the National Eye Institute Visual Function Questionnaire - 25 (NEI VFQ-25) French Version: In a Population of Patients Treated for Ocular Hypertension an...
Nordmann, Jean-Phillipe; Viala, Muriel; Sullivan, Kate; … - In: PharmacoEconomics 22 (2004) 3, pp. 197-206
Objective: Physicians need reliable, valid and sensitive questionnaires to assess QOL related to glaucoma or ocular hypertension. This article presents the psychometric properties of the French version of the National Eye Institute Visual Function Questionnaire - 25 (NEI VFQ-25). Methods: A mail...
Persistent link: https://www.econbiz.de/10005243156
Cover Image
Preferences of Patients with Diabetes Mellitus for Inhaled versus Injectable Insulin Regimens
Chancellor, Jeremy; Aballea, Samuel; Lawrence, Alison; … - In: PharmacoEconomics 26 (2008) 3, pp. 217-234
Background: In clinical trials, patients have expressed greater satisfaction with inhaled human insulin (EXUBERA(R), Pfizer) than with injectable insulin. No studies to date have attempted to quantify the strength of preferences for these alternative routes of administration. Objective: To...
Persistent link: https://www.econbiz.de/10005243213
Cover Image
The Impact of Co-Morbidity Burden on Preference-Based Health-Related Quality of Life in the United States
Sullivan, Patrick W.; Ghushchyan, Vahram H.; Bayliss, … - In: PharmacoEconomics 30 (2012) 5, pp. 431-442
Background:Background: Many statistical analyses, clinical trials and cost-utility analyses designed to measure the impact of a particular disease on utility scores often overlook the important influence of co-morbidity burden. Abstract: Objectives:Objectives: This study aims to examine the...
Persistent link: https://www.econbiz.de/10010541099